- Home
- GCO vs ABEO Comparison
GCO vs ABEO Comparison
Compare GCO & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCO
- ABEO
- Stock Information
- Founded
- GCO 1924
- ABEO N/A
- Country
- GCO United States
- ABEO United States
- Employees
- GCO N/A
- ABEO N/A
- Industry
- GCO Clothing/Shoe/Accessory Stores
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- GCO Consumer Discretionary
- ABEO Health Care
- Exchange
- GCO Nasdaq
- ABEO Nasdaq
- Market Cap
- GCO 314.3M
- ABEO 277.6M
- IPO Year
- GCO N/A
- ABEO 1980
- Fundamental
- Price
- GCO $29.60
- ABEO $5.86
- Analyst Decision
- GCO Hold
- ABEO Strong Buy
- Analyst Count
- GCO 2
- ABEO 3
- Target Price
- GCO $31.00
- ABEO $18.00
- AVG Volume (30 Days)
- GCO 132.3K
- ABEO 292.3K
- Earning Date
- GCO 11-29-2024
- ABEO 11-14-2024
- Dividend Yield
- GCO N/A
- ABEO N/A
- EPS Growth
- GCO N/A
- ABEO N/A
- EPS
- GCO N/A
- ABEO N/A
- Revenue
- GCO $2,301,050,000.00
- ABEO N/A
- Revenue This Year
- GCO N/A
- ABEO N/A
- Revenue Next Year
- GCO $1.43
- ABEO $7,097.06
- P/E Ratio
- GCO N/A
- ABEO N/A
- Revenue Growth
- GCO N/A
- ABEO 147.52
- 52 Week Low
- GCO $23.21
- ABEO $3.05
- 52 Week High
- GCO $37.89
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- GCO 55.32
- ABEO 38.62
- Support Level
- GCO $28.70
- ABEO $5.95
- Resistance Level
- GCO $31.75
- ABEO $6.78
- Average True Range (ATR)
- GCO 1.27
- ABEO 0.32
- MACD
- GCO 0.32
- ABEO -0.07
- Stochastic Oscillator
- GCO 68.80
- ABEO 7.07
About GCO Genesco Inc.
Genesco Inc sells footwear, headwear, sports apparel, and accessories. The company has four reportable segments namely Journeys Group, derives maximum revenue which comprised of Journeys, Journeys Kidz, and Little Burgundy retail footwear chains, e-commerce operations, and catalog. Its Schuh Group is comprised of the Schuh retail footwear chain and e-commerce operations. The Johnston & Murphy Group is comprised of Johnston & Murphy retail operations, e-commerce operations, and catalog and wholesale distribution of products under the Johnston & Murphy and Genesco Brands Group. Licensed Brands, comprised of Dockers Footwear, under a license from Levi Strauss & Company.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.